Exeter Considered for New Bioscience Hub
Exeter Considered for New Bioscience Hub
A quiet city with bold ambitions — and it may soon become a global player in life sciences.
Is Exeter the UK’s Next Bioscience Hotspot?
The South West isn’t typically the first place that comes to mind when talking about cutting-edge science. But that might be about to change.
Exeter is being actively considered as the location for a new national bioscience hub, potentially bringing high-skill jobs, research funding, and advanced manufacturing to the region. Backed by local government interest and key private stakeholders, this move could reposition the city as a serious player in pharmaceuticals, biotechnology, and medical research.
The proposed site would offer laboratory space, cleanroom infrastructure, and dedicated R&D facilities aimed at early-stage biotech firms and specialised chemical manufacturers.
“The demand for high-integrity bio-manufacturing is exploding. Regions like Exeter offer untapped potential—strong universities, available land, and a growing talent pool,” said Dr. Nadia Clarke, a UK Biotech Futures advisor.
ARCHEM to Relocate SARMs Reference Standard Manufacturing
One of the biggest early commitments to the new hub is from ARCHEM, a UK based SARMs reference standards producer used in academic and preclinical research.
The company has announced plans to move its entire analytical chemistry division and reference standard manufacturing to the Exeter site — a major endorsement of the region’s capabilities.
“We’ve outgrown our current facility. Exeter’s bioscience hub offers the lab-grade infrastructure and logistical access we need to scale,” said ARCHEM’s Director of Operations, Daniel Holt.
ARCHEM is known for producing GMP-grade SARMs and androgen receptor ligands for use in non-human laboratory research, with an emphasis on:
- Ultra-pure compound isolation (HPLC-verified)
- Lot-to-lot reproducibility
- COA-backed reference supply to research institutions worldwide
The move would not only boost ARCHEM’s operational capacity but also anchor the bioscience hub with real-world, revenue-generating biotech manufacturing from day one.
Why Exeter? Strategic Location, Smart Investment
So why Exeter, and why now?
- Location: Close to Bristol and London with motorway and rail access
- Talent: Home to the University of Exeter, with strong biomedical and chemistry programs
- Affordability: Lower commercial property costs than Oxford, Cambridge or London
- Demand: Soaring UK and EU need for clinical-grade reference materials
Local authorities are reportedly reviewing planning applications and funding structures, with potential for public-private partnerships and tax incentives for bioscience firms relocating to the area.
What This Means for the Industry
If approved, the Exeter bioscience hub could become a model for regional biotech clusters, combining academic insight with commercial lab space and regulatory-compliant infrastructure. It also marks a move away from the “golden triangle” monopoly of Cambridge–London–Oxford.
And with players like ARCHEM already signed on, it’s not just talk — it’s a pipeline.
